LLY Eli Lilly and Co
- 755.910
- -20.840-2.68%
- 746.150
- -9.760-1.29%
Eli Lilly and Co News
Canto Fitzgerald: Maintaining the Eli Lilly and Co (LLY.US) rating, adjusted from an increase holdings to an increase rating, and the target price was adjusted from $815.00 to $885.00.
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
Truist Securities Maintains Buy on Eli Lilly and Co, Raises Price Target to $892
Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723
Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825
Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating
Eli Lilly and Co Analyst Ratings
Cantor Fitzgerald Company: Reiterated the Eli Lilly and Co (LLY.US) rating, adjusted from an increase holdings to an increase rating, and the target price was adjusted from $815.00 to $885.00.
Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Raises Price Target to $885
Jefferies Adjusts Eli Lilly and Co.'s Price Target to $915 From $895, Keeps Buy Rating
Cantor Fitzgerald Company: Reiterates the Eli Lilly and Co (LLY.US) rating and adjusted from an increase to an increase in holdings rating, with a target price of $815.00.
Eli Lilly and Co Analyst Ratings
Eli Lilly Stock (NYSE:LLY): Hold Off Until the End of the Month
Eli Lilly and Co Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $815 Price Target
BMO Raises Price Target on Eli Lilly to $900 From $865
Goldman Sachs: Maintaining the Eli Lilly and Co (LLY.US) rating, adjusted from neutral to neutral, and adjusted the target price from $650.00 to $723.00.
Eli Lilly and Co Analyst Ratings
Eli Lilly and Co Analyst Ratings
Eli Lilly and Co Analyst Ratings
Analysis
Price Target
No Data
